Document ID: chunk:federal_register_of_legislation:F2022C00891:reg:9
Version: federal_register_of_legislation:F2022C00891
Segment Type: reg
Provision Reference: reg 9
Character Range: 5808–8857

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting malignant neoplasm of the cervix or death from malignant neoplasm of the cervix with the circumstances of a person's relevant service:
(1)          having a persistent infection of the cervical epithelium with a specified human papillomavirus before the clinical onset of malignant neoplasm of the cervix;
Note: persistent infection and specified human papillomavirus are defined in the Schedule 1 - Dictionary.
(2)          having infection with human immunodeficiency virus before the clinical onset of malignant neoplasm of the cervix;
(3)          for squamous cell carcinoma of the cervix only, having smoked at least 10 pack-years of tobacco products, at least two years before the clinical onset of squamous cell carcinoma of the cervix, and where smoking has ceased, the clinical onset of squamous cell carcinoma of the cervix has occurred within 20 years of cessation;
            Note: one pack-year is defined in the Schedule 1 - Dictionary.
(4)          taking a combined oral contraceptive pill for a continuous period of at least three years, commencing at least five years before the clinical onset of malignant neoplasm of the cervix, and where taking the combined oral contraceptive pill has ceased, the clinical onset of malignant neoplasm of the cervix has occurred within 15 years of cessation;
            Note: combined oral contraceptive pill is defined in the Schedule 1 - Dictionary.
(5)          taking an immunosuppressive drug for organ or tissue transplantation at least two years before the clinical onset of malignant neoplasm of the cervix;
            Note: organ or tissue transplantation is defined in the Schedule 1 - Dictionary.
(6)          having systemic lupus erythematosus within the five years before the clinical onset of malignant neoplasm of the cervix;
(7)          being prevented from accessing clinical screening for cervical precancerous lesions or cervical cancer in accordance with contemporary medical standards of the time, within the seven years before the clinical onset of malignant neoplasm of the cervix, and where:
(a)          if clinical screening has subsequently resumed, there has been no normal test result; and
(b)          the opportunity for subsequent clinical screening has not been declined;
Note: cervical precancerous lesions and clinical screening for cervical precancerous lesions or cervical cancer are defined in the Schedule 1 - Dictionary.
(8)          being prevented from accessing appropriate treatment for cervical precancerous lesions in accordance with contemporary medical standards of the time, between two and seven years before the clinical onset of malignant neoplasm of the cervix;
            Note: cervical precancerous lesions is defined in the Schedule 1 - Dictionary.
(9)          inability to obtain appropriate clinical management for malignant neoplasm of the cervix.